Font Size:
a
A
A
Keyword [Third-generation EGFR-TKIs]
Result: 1 - 4 | Page: 1 of 1
1.
Filamin A Is Correlated With Sensitivity To Third Generation EGFR-TKIs In Lung Adenocarcinoma H1975 Cell With EGFR T790M Mutation
2.
The Mechanisms Underlying The Synergistic Antitumor Activity Of Multi-targeted Tyrosine Kinase Inhibitor Famitinib And The Third-generation EGFR Inhibitor HS-10296 As Well As The Antitumor Activity Of The Novel Antibody-drug Conjugates Targeting CD79b
3.
The Efficacy And Safety Of Third-generation EGFR-TKIs Combined With Bevacizumab And Intrathecal Pemetrexed In The Treatment Of Leptomeningeal Metastasis With EGFR Mutant Non-small Cell Lung Cancer
4.
Prognostic Role Of Peripheral Blood Inflammatory Markers In Patients With Advanced NSCLC Treated With Third-generation EGFR-TKIs
<<First
<Prev Next>
Last>>
Jump to
